Genetic variations of the CTNNA1 and the CTNNB1 genes in sporadic colorectal cancer in Polish population;Zmienność genów CTNNA1 i CTNNB1 u pacjentów ze sporadycznym rakiem jelita grubego w populac ji polskiej

Polski Przeglad Chirurgiczny/ Polish Journal of Surgery

Volumn 84, Issue 11, 2012, Pages 999-1007

  Sygut, Andrzej ^a   Przybyłowska, Karolina ^a   Ferenc, Tomasz ^a   Dziki, Łukasz ^a   Spychalskf, Michał ^a   Mik, Michał ^a   Dziki, Adam ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adhesion molecules; Catenin gene; Muations; Sporadic colorectal cancer

Indexed keywords

EID: 84880534247     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wijnhouen BP, Dinjens WN, Pignatelli M: E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000;87:992-1005.
2. Schölten AN, Aliredjo R, Creutzberg CL, Smit VT: Combined E-cadherin, -catenin, and -catenin expression is a favorable prognostic factor in endometrial carcinoma. Int J Gynecol Cancer 2006;16:1379-85.
3. Kobielak A, Fuchs E: Alpha-catenin: at the junction of intercellular adhesion and actin dynamics. Nat Rev Mol Cell Biol 2004;5(8):614-25.
4. Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-57.
5. Lustig B, Behrens J: The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003;129:199-221.
6. Shimoyama Y et al.: Cadherin dysfunction in a human cancer cell line: possible involvement of loss of a-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992;52:5770-74.
7. Morton RA, Ewing CM, Nagafuchi A et al.: Reduction of E-cadherin levels and deletion of the a-catenin gene in human prostate cancer cells. Cancer Res 1993;53:3585-90.
8. Vermeulen SJ, Nollet F, Teugels E et al.: The alphaE-catenin gene (CTNNAl) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene 1999;28;18(4):905-15.
9. Shibata H, Takano H, Ito M et al.: Alpha-catenin is essential in intestinal adenoma formation. Proc Natl Acad Sci USA. 2007;104(46):18199-204.
10. Giannini AL, Vivanco M, Kypta RM: alphacatenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex. J Biol Chern 2000;21;275(29):21883-88.
11. Baldus SE, Monig SP, Huxel S et al.: MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 2004;10:2790-96.
12. Raftopoulos I, Davaris P, Karatzas G et al.: Level of alpha-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential, and survival. J Surg Oncol 1998;68(2):92-99.
13. Kim IJ, Kang HC, Park JH et al.: Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. Clin Cancer Res 2003;1;9(8):2920-25.
14. Albuquerque C, Baltazar C, Filipe B et al.: Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer 2010;49(8):746-59.
15. Vanpoucke G, Nollet F, Tejpar S et al.: The human alphaE-catenin gene CTNNA1: mutational analysis and rare occurrence of a truncated splice variant. Biochim Biophys Acta 2002;12;1574(3):262-68.
16. Ebert MP, Fei G, Kahmann S et al.: Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002;23(1):87-91.
17. Iwao K, Nakamori S, Kameyama M et al. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 1998;58:1021-26.
18. Khiari M, Arfaoui A, Kriaa L et al.: The prognostic value of the immunohistochemical expression and mutational pattern of the key mediator of Wnt signaling: beta-catenin in Tunisian patients with colorectal carcinoma. Appl Immunohistochem Mol Morphol 2012;20(1):62-70.
19. Kitaeva MN, Grogan L, Williams JP et al.: Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res 1997;57:4478-81.
20. Langner E, Przybylowska K, Trzcinski R et al.: Loss of hMSH2 gene expression correlates with improved survival in patients with sporadic colorectal cancer. J Genet 2010;89(1):101-04.
21. Glebov OK, Rodriguez LM, Nakahara K et al.: Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomark Prev 2003;12:755-62.
22. Sugai T, Habano W, Jiao YF et al.: Analysis of molecular alterations in left-and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: Proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 2006;8:193-201.
23. Shiozaki H, Iihara K, Oka H et al.: Immunohistochemical detection of alpha-catenin expression in human cancers. Am J Pathol 1994;144:667-74
24. Gofuku J, Shiozaki H, Tsujinaka T et al.: Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Am J Clin Pathol 1999;111:29-37.